Michael Romano,
CPA
Director DIA
Partner, Life Science Industry Practice Group, RSM US
Michael Romano is a Partner and leader of the Life Sciences Industry practice group for RSM in the Greater Atlantic area; is a Partner in the Technology and Management Consulting practice at RSM; and leads the Finance and Accounting Outsourcing group for RSM in Blue Bell (PA). In these capacities, Michael assists clients with accounting and financial reporting requirements, capital raises, financial and operational restructurings, strategic direction and execution, and providing leadership and financial guidance to grow their businesses. Michael has over 25 years of diverse experience in both the life sciences industry and, having started his career with a Big Four accounting firm, as an audit and business consultant. In more than a decade of life sciences industry experience, he has been responsible for general management, financial management, M&A, and global operations. Michael has orchestrated successful financial and operational turnarounds, restructured and reorganized businesses, and successfully executed growth strategies. Michael gained in-depth experience in pharmaceutical outsourcing by serving as Vice President and General Manager of a global medical publisher offering health information products and services to the pharmaceutical, biotech, and medical device markets. He also spent several years working for a privately held specialty medical communications company, and with a clinical research and contract manufacturing organization, and began his career in the auditing practice of EY in Philadelphia. Michael is an ad-hoc member of the Audit Committee in DIA’s Board of Directors. He earned his dual Bachelor’s degree in Accounting and Finance from Drexel University.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China